Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate if Internet delivered emotion regulation individual therapy for adolescents is an efficacious treatment when delivered as adjunctive to treatment as usual compared to a control group consisting of treatment as usual.
Statistical Analyses
Treatment effects will be evaluated according to the intention-to-treat principle. Primary end-point for all outcomes is post-treatment. Secondary end-point include a controlled 3 month follow-up.
Primary Analysis
The primary outcome analysis will include treatment group (ERITA , TAU) and weekly reports of NSSI frequency measured once every week 4 weeks prior to treatment start, once every week during treatment, and once every week four weeks after treatment termination. Regression analysis modelled for count data will be used to estimate trend over time. Four weeks after treatment termination will be considered primary endpoint. Pairwise contrasts (group x time interaction) from the regression model will be used to evaluate between-group differences at primary endpoint (4 weeks after treatment termination).
Secondary Analyses
Secondary outcomes measured once before, during, and after treatment will be analyzed in a similar fashion as for the primary outcome, modelled after data's distribution (count or continuous). Measures collected only once at baseline and post-treatment will be analyzed with regression analyses including treatment group (online ERITA , TAU) as the between-subjects factor, time (baseline to post) as the within-subjects factor, and group × time interactions, modelled after data's distribution (count or continuous).
Parallel process latent growth curve modeling will be used to determine whether change in week-to-week emotion dysregulation (DERS-16) during treatment mediate the overall effect of ERITA+ETAU on week-to-week change in the primary outcome self-rated NSSI frequency (DSHI-Y).
3 Month Follow-Up
Data collected at 3-month follow-up will be used to determine the extent to which potential treatment gains were maintained both within and between treatment conditions
Update 28 April 2022: As a secondary analyses, we also aim to investigate the effect of treatment moderators (primary aim) and predictors (secondary aim) on NSSI frequency one month after treatment termination. This update was submitted prior to conducting the analyses.
The selection of potential moderators was theoretically and empirically motivated. We will investigate the following variables (measured at baseline):
Age Difficulties in emotion regulation As measured with the Difficulties in Emotion Regulation Scale - 36 item version (DERS) Past month NSSI frequency As measured with the Deliberate Self-Harm Inventory Youth version (DSHI-Y) Global functioning As measured with the Childrens Global Assessment Scale Depressive symptoms As measured with the 21-item Depression Anxiety Stress Scales (DASS-21) Sleep difficulties As measured with the Insomnia Severity Index (ISI) Parental Minimization - discounting or devaluing the child's negative emotions/problems As measured with The Coping with Children's Negative Emotions Scale Adolescent Version (CCNES-A), subscale minimazation Level of suicidality As measured with the MINI-KID International Neuropsychiatric Interview, version 6
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Adjunctive Internet-delivered ERITA | Experimental | Participants will receive 11 weeks of internet-delivered emotion regulation individual therapy with therapist support adjunctive to treatment as usual as provided in the community. The caregiver(s) will receive 6 modules of internet-delivered parent program with therapist support. |
|
| Treatment as usual | Active Comparator | Participants will receive treatment as usual for 11 weeks of treatment as usual as provided in the community. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Emotion regulation individual therapy | Behavioral | The emotion regulation individual therapy is delivered via an internet platform and includes therapist contact several times per week via the platform. |
| Measure | Description | Time Frame |
|---|---|---|
| Deliberate Self-Harm Inventory Youth version (DSHI-Y) | Frequency of nonsuicidal self-injury | Change from baseline, once every week during treatment (0-12 weeks after baseline), 3 and 12 months after treatment has ended |
| Measure | Description | Time Frame |
|---|---|---|
| Difficulties in Emotion Regulation Scale - 16 item version (DERS-16) | Difficulties in emotion regulation as primary potential mechanism of change. Ranges from 16-80, with higher scores indicating more difficulties. | Change from baseline, once every week during treatment (0-12 weeks after baseline), 3 and 12 months after treatment has ended |
| Measure | Description | Time Frame |
|---|---|---|
| Short version of the Experiences in Close Relationships Scale - Revised Child version | Experiences in close relationships. Ranges from 12-84, with higher scores indicating greater problems. | Change from baseline, once every second week during treatment (0-12 weeks after baseline) |
| Generalised Anxiety Disorder 7-item scale |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Clara Hellner, PhD, MD | Karolinska Institutet | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre for Psychiatry Research Karolinska Institutet and Stockholm County Council | Stockholm | 113 64 | Sweden | |||
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41611448 | Derived | Ojala O, Sjoblom K, Hesser H, Hedman-Lagerlof E, Hellner C, Bjureberg J. Parents' coping with their adolescent's negative emotions following internet-delivered emotion regulation therapy for adolescents with non-suicidal self-injury disorder: a secondary analysis of a randomised clinical trial. BMJ Ment Health. 2026 Jan 29;29(1):e302039. doi: 10.1136/bmjment-2025-302039. | |
| 39695442 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016728 | Self-Injurious Behavior |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Treatment as usual | Behavioral | Treatment as usual as provided in the community. |
|
| Difficulties in Emotion Regulation Scale - 36 item version (DERS) |
Difficulties in emotion regulation. Ranges from 36-180, with higher scores indicating more difficulties. |
| Change from baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended |
| the 21-item Depression Anxiety Stress Scales (DASS-21) | Symptoms of depression, anxiety and stress. Each subscale (depression, anxiety and stress) ranges from 0-21, with higher scores indicating more symptoms. | Change from baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended |
| Borderline Symptom List Supplement | Impulsive self-destructive behaviors | Change from baseline, once every week during treatment (0-12 weeks after baseline), 3 and 12 months after treatment has ended |
| Acceptance and Action Questionnaire | Acceptance and valued actions. Ranges from 7-49, with higher scores indicating less acceptance and valued actions. | Change from baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended |
| Childrens Global Assessment Scale | Global functioning. Ranges from 1-100, with higher scores indicating better functioning. | Change from baseline, 16 weeks after treatment starts, 3 months after treatment has ended |
| The Clinical Global Impressions -Severity and Improvement scales | Global symptom severity and improvement. Severity of illness scale ranges from 1-7, with higher scores indicating higher severity of illness. Global improvement scale ranges from 1-7 with lower scores indicating more improvement. | Change from baseline, 16 weeks after treatment starts, 3 months after treatment has ended |
Worry. Ranges 0-21, with higher scores indicating more worry. |
| Change from baseline, once every second week during treatment (0-12 weeks after baseline) |
| Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness - Child version | Costs associated with psychiatric illness | Change from baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended |
| Kidscreen-10 | Quality of life. Ranges 11-55, with higher scores indicating higher quality in life. | Change from baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended |
| Patient Internet-delivered cognitive behavioral Adherence Scale | Patient adherence to treatment. Ranges from 0-20, with higher scores indicating higher adherence. | 6 and 12 weeks after baseline |
| Working Alliance Inventory | Working alliance with online therapist | 4 weeks after treatment starts |
| The Coping with Children's Negative Emotions Scale Adolescent Version | Parents' perceived ability to cope with children's negative emotions. Three subscales will be used derived to reflect the specific types of coping response parents tend to use in these situations (punitive reactions, problem focused reactions, and minimization reactions). Each subscale ranges from 1-7. | Change from baseline, 6 and 12 weeks after treatment starts, 3 and 12 months after treatment has ended |
| The Client Satisfaction Questionnaire | Client satisfaction with treatment. Ranges from 8-32 with higher scores indicating greater treatment satisfaction. | 12 weeks after treatment starts |
| Adverse Events | Self-rating scale that measures adverse events related to treatment | 12 weeks after treatment starts |
| Credibility/Expectancy Questionnaire | Treatment credibility and expectancy. Ranges from 0-50 with higher scores indicating greater credibility/expectancy. | 1 week after treatment starts |
| Karolinska Institutet |
| Stockholm |
| 113 64 |
| Sweden |
| Derived |
| Ponten M, Flygare O, Bellander M, Karemyr M, Nilbrink J, Hellner C, Ojala O, Bjureberg J. Comparison between clinician and machine learning prediction in a randomized controlled trial for nonsuicidal self-injury. BMC Psychiatry. 2024 Dec 18;24(1):904. doi: 10.1186/s12888-024-06391-x. |
| 37440232 | Derived | Bjureberg J, Ojala O, Hesser H, Habel H, Sahlin H, Gratz KL, Tull MT, Claesdotter Knutsson E, Hedman-Lagerlof E, Ljotsson B, Hellner C. Effect of Internet-Delivered Emotion Regulation Individual Therapy for Adolescents With Nonsuicidal Self-Injury Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2023 Jul 3;6(7):e2322069. doi: 10.1001/jamanetworkopen.2023.22069. |
| 33677832 | Derived | Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Interventions for self-harm in children and adolescents. Cochrane Database Syst Rev. 2021 Mar 7;3(3):CD013667. doi: 10.1002/14651858.CD013667.pub2. |